Clinical trials
Atherosclerosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
105 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 11 |
| 2022 | 12 |
| 2023 | 4 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 37 |
| Completed | 32 |
| Recruiting | 19 |
| Active, not recruiting | 10 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xuanwu Hospital, Beijing | 9 |
| Peking Union Medical College Hospital | 6 |
| Novartis Pharmaceuticals | 5 |
| Amgen | 4 |
| China National Center for Cardiovascular Diseases | 4 |
| Beijing Inno Medicine Co., Ltd. | 3 |
| Eli Lilly and Company | 3 |
| GlaxoSmithKline | 3 |
| Sun Yat-sen University | 3 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 105 |
| Cardiovascular Diseases | 13 |
| Coronary Artery Disease | 10 |
| Stroke | 9 |
| Coronary Disease | 8 |
| Dyslipidemias | 6 |
| Ischemia | 6 |
| Diabetes Mellitus | 5 |
| Hyperlipidemias | 5 |
| Ischemic Stroke | 5 |
Trials
Showing 51 to 75 of 105. Each trial links to its page on Pharma Observatory.
5 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.